Dennis Cesar, MD
Urology · Merced
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 9
- 1 carrier
- Office
- 1
- Since medical school
- 54 years
- Georgetown University School of Medicine, 1972
Offices
1 location · Merced Urology Medical Group, Inc. · 3 clinicians in this group
Hospitals listed: John C Fremont Healthcare District · Memorial Hospital Los Banos · Mercy Medical Center. That is not proof they admit you there this week.
Plans that list them
9 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Cesar’s office at (209) 723-2122 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence G33716 · Current
Licensed to practise in California · since 1977 · expires 2027-01-31 · Georgetown University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
3 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- John C Fremont Healthcare DistrictMariposa, CACritical Access Hospital · Government - Hospital District or Authority · Has an emergency department54% would definitely recommend itNo overall ratingNo measure marked better or worse than the national rate
- Memorial Hospital Los BanosLos Banos, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 59% would definitely recommend itOverall rating: 3 of 5 starsNo measure marked better or worse than the national rate
- Mercy Medical CenterMerced, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of CommonSpirit Health, which runs 145 hospitals in 19 statesPatients rate it 3 of 5 · 59% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.168, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.364, Oct 2024 – Sep 2025
See every measure and the patient survey for John C Fremont Healthcare District
Behind the star rating — Deaths: 0 better, 2 the same, 0 worse of 2 measures. Readmissions: 0 better, 1 the same, 1 worse of 2 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate for COPD patientsComplications and deaths | 9 · 31 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 12.3 · 26 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.3 · 43 cases | None | Jul 2022 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4.1 · 121 cases | None | Jul 2024 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -28.9 · 28 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 44.5 · 39 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.5 · 27 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.2 · 33 cases | None | Jul 2023 – Jun 2025 |
| Room was "always" clean | 84% |
| Nurses "always" communicated well | 72% |
| Doctors "always" communicated well | 72% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 94% |
| Patients who gave a rating of "9" or "10" (high) | 55% |
| "Always" quiet at night | 35% |
| "YES", patients would definitely recommend the hospital | 54% |
See every measure and the patient survey for Memorial Hospital Los Banos
Behind the star rating — Deaths: 0 better, 4 the same, 0 worse of 4 measures. Safety: 0 better, 2 the same, 0 worse of 2 measures. Readmissions: 0 better, 3 the same, 0 worse of 3 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.04 (0 to 2.13) · 48 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.94 (0.46 to 1.43) | No different | Jul 2022 – Jun 2024 |
| Death rate for heart failure patientsComplications and deaths | 14.5 · 47 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 16.4 · 72 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.5 · 33 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4.6 · 324 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.21 (0 to 0.44) · 797 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.05 to 0.48) · 753 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.36 (0.77 to 5.95) · 105 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.31 (0.58 to 4.03) · 100 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.76 (0.23 to 3.29) · 31 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.49 (0 to 1.69) · 573 cases | No different | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.9 · 56 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 20.3 · 47 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 34.5 · 80 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18 · 86 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.5 (9.8 to 18.5) · 59 cases | No different | Jan 2022 – Dec 2024 |
What patients said (172 patients answered, 12% of those asked)
| Cleanliness | 5 |
| Nurse communication | 4 |
| Doctor communication | 2 |
| Communication about medicines | 3 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 81% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 64% |
| Yes, staff "did" give patients this information | 80% |
| Yes, staff "did" give patients information about help after discharge | 75% |
| Doctors "always" explained things so they could understand | 73% |
| Doctors "always" listened carefully | 73% |
| Doctors "always" treated them with courtesy and respect | 81% |
| Patients who gave a rating of "9" or "10" (high) | 71% |
| Staff "always" explained new medications | 82% |
| Nurses "always" explained things so they could understand | 78% |
| Nurses "always" listened carefully | 77% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 48% |
| "YES", patients would definitely recommend the hospital | 59% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Mercy Medical Center
Behind the star rating — Deaths: 0 better, 5 the same, 1 worse of 6 measures. Safety: 3 better, 3 the same, 0 worse of 6 measures. Readmissions: 0 better, 7 the same, 2 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.168 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.364 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.1 (0.11 to 2.09) · 798 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.74 (0.37 to 1.11) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.7 · 165 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.7 · 69 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.3 · 449 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 17.5 · 544 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11 · 206 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.6 · 1,843 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.37) · 5,594 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.03 to 0.43) · 5,647 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.53 (0.28 to 4.78) · 763 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.64 (0 to 3.35) · 161 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.96 (0.37 to 3.55) · 791 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.67 (0 to 16.88) · 163 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.84 (0.67 to 9.02) · 115 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.92 (0.46 to 3.38) · 273 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.16 (0 to 0.85) · 4,979 cases | No different | Jul 2022 – Jun 2024 |
| MRSA BacteremiaInfections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.764 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14 · 31 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.5 · 477 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 62.8 · 511 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 43.6 · 554 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.8 · 462 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.8 to 8.2) · 152 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.7 (8 to 14.1) · 152 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.9 · 196 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.9 (10.2 to 19) · 70 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.4) · 413 cases | No different | Jan 2024 – Dec 2024 |
What patients said (394 patients answered, 11% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 3 |
| Recommend hospital | 2 |
| Room was "always" clean | 73% |
| Nurses "always" communicated well | 78% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 83% |
| Doctors "always" explained things so they could understand | 73% |
| Doctors "always" listened carefully | 72% |
| Doctors "always" treated them with courtesy and respect | 80% |
| Patients who gave a rating of "9" or "10" (high) | 64% |
| Staff "always" explained new medications | 74% |
| Nurses "always" explained things so they could understand | 74% |
| Nurses "always" listened carefully | 75% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 49% |
| "YES", patients would definitely recommend the hospital | 59% |
| Staff "always" explained possible side effects | 49% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$499,518
Medicare paid this office $499,518 for 1,284 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 1,130 | $159,253 | $63 |
| Leuprolide injectable, camcevi, 1 mg | 36 | $92,560 | None |
| Ultrasound scan of pelvic region through rectum | 234 | $26,307 | $106 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 28 | $17,921 | None |
| Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope | 33 | $17,823 | $540 |
See all 25 services
| Short return visit (20+ min) | 1,130 | $159,253 | $63 |
| Leuprolide injectable, camcevi, 1 mg | 36 | $92,560 | None |
| Ultrasound scan of pelvic region through rectum | 234 | $26,307 | $106 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 28 | $17,921 | None |
| Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope | 33 | $17,823 | $540 |
| Complex measurement of pressure of urine flow in bladder with voiding pressure studies | 59 | $17,145 | $286 |
| Diagnostic exam of bladder and urethra using an endoscope | 77 | $14,283 | $172 |
| Long return visit (40+ min) | 87 | $12,272 | $131 |
| Dilation of urethra using an endoscope | 44 | $11,951 | $249 |
| Simple insertion of temporary bladder tube | 59 | $10,639 | $46 |
| Ultrasound measurement of bladder capacity after voiding | 705 | $10,255 | $8 |
| New patient visit (45+ min) | 87 | $9,551 | $110 |
| Shock wave crushing of kidney stones | 13 | $6,358 | $424 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 37 | $3,971 | $99 |
| Simple measurement of pressure of urine flow in bladder | 30 | $2,805 | $94 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 44 | $2,788 | $29 |
| Injection of drug or substance under skin or into muscle | 47 | $1,965 | $11 |
| Limited ultrasound scan of pelvis | 45 | $1,781 | $40 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 62 | $1,604 | $25 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 16 | $1,499 | $60 |
| Telephone medical discussion with physician, 11-20 minutes | 22 | $1,433 | $65 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 49 | $1,155 | $18 |
| Electronic assessment of bladder emptying | 62 | $352 | $6 |
| Simple timed assessment of bladder emptying | 31 | $177 | $6 |
| Injection, garamycin, gentamicin, up to 80 mg | 22 | $54 | None |
Procedures Medicare counted
| Prostate resection | 29 | More than 89% of doctors who do this |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Ultrasound measurement of bladder capacity after voiding | 713 | 748 | 1,371 | 1,350 | 1,155 | 1,229 |
| Simple insertion of temporary bladder tube | 220 | 299 | 310 | 263 | 223 | 233 |
| Insertion of lower leg neurostimulator electrode | 252 | 282 | 239 | 331 | 258 | – |
| Diagnostic exam of bladder and urethra using an endoscope | 148 | 163 | 163 | 159 | 120 | 83 |
| Electronic assessment of bladder emptying | 31 | 16 | 101 | 246 | 118 | 63 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | – | – | 69 | 248 | 119 | 63 |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
1,284 Original Medicare patients in 2024. Average age 76 · Under 65 7% · 85 and older 16% · Women 21% · Also on Medicaid 33% · Health risk score 1.31. At or below the middle of the specialty; the typical urology clinician is at 1.36.
Conditions among them: High blood pressure 75% · Diabetes 44% · Coronary heart disease 32% · Chronic kidney disease 28% · Atrial fibrillation 22% · Heart failure 21% · Cancer 21% · COPD 18% · Depression 11% · Stroke 9% · Dementia 8%.
The office billed $1,460,396, Medicare allowed $671,943 and paid $499,518; for 30,937 services of 71 kinds; $149,125 of it was for drugs given in the office and $350,393 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 1,284 | 30,937 | 76 | 1.31 | $1,460,396 | $499,518 |
| 2023 | 1,447 | 34,612 | 76 | 1.29 | $1,625,740 | $553,529 |
| 2022 | 1,950 | 35,877 | 75 | 1.24 | $2,213,641 | $763,229 |
| 2021 | 1,653 | 45,815 | 75 | 1.28 | $1,768,378 | $683,430 |
| 2020 | 1,483 | 47,020 | 74 | 1.36 | $1,608,081 | $581,635 |
| 2019 | 1,379 | 30,168 | 74 | 1.36 | $1,555,260 | $554,336 |
| 2018 | 1,476 | 31,874 | 74 | 1.39 | $1,792,721 | $564,344 |
| 2017 | 1,450 | 34,950 | 75 | 1.45 | $1,963,853 | $593,549 |
| 2016 | 1,460 | 24,945 | 74 | 1.36 | $2,042,404 | $615,870 |
| 2015 | 1,470 | 36,737 | 74 | 1.36 | $2,234,331 | $663,377 |
| 2014 | 1,501 | 11,862 | 74 | 1.26 | $2,311,288 | $686,767 |
| 2013 | 1,474 | 12,335 | 74 | 1.30 | $2,455,047 | $723,441 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 27 services
| Short return visit (20+ min) | 1,237 | $185,897 | $63 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 48 | $46,594 | None |
| Complex measurement of pressure of urine flow in bladder with voiding pressure studies | 115 | $34,302 | $293 |
| Ultrasound scan of pelvic region through rectum | 291 | $33,130 | $105 |
| Insertion of lower leg neurostimulator electrode | 28 | $23,248 | $90 |
| Diagnostic exam of bladder and urethra using an endoscope | 106 | $22,046 | $184 |
| New patient visit (45+ min) | 187 | $20,454 | $109 |
| Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope | 33 | $18,191 | $551 |
| Dilation of urethra using an endoscope | 59 | $17,071 | $259 |
| Long return visit (40+ min) | 85 | $12,033 | $128 |
| Injection, degarelix, 1 mg | 13 | $10,874 | None |
| Simple insertion of temporary bladder tube | 68 | $10,268 | $46 |
| Ultrasound measurement of bladder capacity after voiding | 664 | $9,619 | $8 |
| Shock wave crushing of kidney stones | 12 | $7,252 | $518 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 44 | $4,610 | $102 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 49 | $3,664 | $28 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 117 | $3,126 | $26 |
| Complex measurement of pressure of urine flow in bladder | 15 | $2,921 | $195 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 24 | $2,332 | $63 |
| Injection of drug or substance under skin or into muscle | 69 | $1,779 | $10 |
| Simple measurement of pressure of urine flow in bladder | 17 | $1,630 | $96 |
| Limited ultrasound scan of pelvis | 35 | $1,342 | $36 |
| Telephone medical discussion with physician, 11-20 minutes | 25 | $1,292 | $52 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 54 | $1,213 | $18 |
| Electronic assessment of bladder emptying | 116 | $671 | $6 |
| Simple timed assessment of bladder emptying | 25 | $142 | $6 |
| Injection, garamycin, gentamicin, up to 80 mg | 40 | $105 | None |
2022: 30 services
| Short return visit (20+ min) | 1,549 | $226,006 | $66 |
| Complex measurement of pressure of urine flow in bladder with voiding pressure studies | 216 | $64,989 | $297 |
| Ultrasound scan of pelvic region through rectum | 421 | $54,169 | $110 |
| New patient visit (45+ min) | 451 | $53,550 | $119 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 52 | $44,194 | None |
| Insertion of lower leg neurostimulator electrode | 34 | $32,902 | $99 |
| Diagnostic exam of bladder and urethra using an endoscope | 141 | $28,155 | $177 |
| Long return visit (40+ min) | 177 | $27,438 | $139 |
| Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope | 38 | $20,737 | $546 |
| Dilation of urethra using an endoscope | 76 | $20,114 | $248 |
| Simple insertion of temporary bladder tube | 79 | $12,596 | $48 |
| Shock wave crushing of kidney stones | 18 | $11,391 | $475 |
| Ultrasound measurement of bladder capacity after voiding | 849 | $11,082 | $8 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | 32 | $10,792 | $327 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 75 | $8,597 | $107 |
| Biopsy of prostate gland | 38 | $7,114 | $187 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 240 | $6,575 | $27 |
| Telephone medical discussion with physician, 11-20 minutes | 69 | $4,126 | $52 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 55 | $3,817 | $28 |
| Injection of drug or substance under skin or into muscle | 80 | $3,047 | $11 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 38 | $3,040 | $57 |
| Insertion of device into abdomen with pressure and urine flow rate study | 15 | $2,733 | $171 |
| Limited ultrasound scan of pelvis | 46 | $2,064 | $39 |
| Ultrasonic guidance for needle placement | 38 | $1,831 | $48 |
| Simple measurement of pressure of urine flow in bladder | 18 | $1,775 | $99 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 71 | $1,618 | $18 |
| Electronic assessment of bladder emptying | 242 | $1,389 | $6 |
| Insertion of temporary bladder tube | 14 | $483 | $35 |
| Simple timed assessment of bladder emptying | 22 | $137 | $6 |
| Injection, garamycin, gentamicin, up to 80 mg | 46 | $94 | None |
2021: 36 services
| Short return visit (20+ min) | 1,293 | $191,016 | $67 |
| Ultrasound scan of pelvic region through rectum | 501 | $64,788 | $112 |
| New patient visit (45+ min) | 424 | $52,914 | $125 |
| Injection, testosterone undecanoate, 1 mg | 12 | $42,532 | None |
| Leuprolide acetate (for depot suspension), 7.5 mg | 45 | $42,344 | None |
| Diagnostic exam of bladder and urethra using an endoscope | 139 | $30,895 | $190 |
| Destruction of prostate tissue using microwave induced heat | 21 | $28,495 | $1,357 |
| Insertion of lower leg neurostimulator electrode | 26 | $25,204 | $105 |
| Dilation of urethra using an endoscope | 76 | $22,013 | $275 |
| Complex measurement of pressure of urine flow in bladder with voiding pressure studies | 61 | $19,278 | $316 |
| Long return visit (40+ min) | 107 | $16,788 | $138 |
| Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope | 27 | $16,036 | $594 |
| Simple insertion of temporary bladder tube | 85 | $15,648 | $50 |
| Ultrasound measurement of bladder capacity after voiding | 881 | $11,509 | $8 |
| Injection, degarelix, 1 mg | 14 | $11,430 | None |
| Shock wave crushing of kidney stones | 17 | $10,321 | $516 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 65 | $7,316 | $106 |
| Biopsy of prostate gland | 31 | $6,134 | $198 |
| Destruction and/or removal of large growth of bladder using an endoscope | 16 | $5,564 | $309 |
| Complicated insertion of bladder tube | 13 | $4,235 | $125 |
| Injection of drug or substance under skin or into muscle | 131 | $4,101 | $11 |
| Telephone medical discussion with physician, 11-20 minutes | 53 | $4,090 | $66 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | 12 | $4,060 | $338 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 28 | $2,981 | $57 |
| Simple measurement of pressure of urine flow in bladder | 28 | $2,739 | $98 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 79 | $2,102 | $16 |
| Return visit (30+ min) | 17 | $1,942 | $108 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 69 | $1,912 | $28 |
| Ultrasonic guidance for needle placement | 32 | $1,536 | $48 |
| Limited ultrasound scan of pelvis | 35 | $1,425 | $39 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 27 | $778 | $28 |
| Insertion of temporary bladder tube | 13 | $690 | $35 |
| Electronic assessment of bladder emptying | 97 | $622 | $6 |
| Simple timed assessment of bladder emptying | 29 | $190 | $7 |
| Injection, garamycin, gentamicin, up to 80 mg | 54 | $83 | None |
| Injection, ketorolac tromethamine, per 15 mg | 13 | $12 | None |
2020: 31 services
| Short return visit (20+ min) | 1,179 | $134,235 | $54 |
| Ultrasound scan of pelvic region through rectum | 451 | $56,230 | $110 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 44 | $51,423 | None |
| Injection, testosterone undecanoate, 1 mg | 11 | $38,511 | None |
| Insertion of lower leg neurostimulator electrode | 34 | $28,638 | $102 |
| Diagnostic exam of bladder and urethra using an endoscope | 140 | $25,954 | $159 |
| New patient visit (60+ min) | 171 | $25,295 | $148 |
| Dilation of urethra using an endoscope | 84 | $23,189 | $255 |
| Destruction of prostate tissue using microwave induced heat | 16 | $20,289 | $1,268 |
| New patient visit (45+ min) | 161 | $20,001 | $124 |
| Long return visit (40+ min) | 139 | $17,985 | $112 |
| Simple insertion of temporary bladder tube | 69 | $14,501 | $48 |
| Shock wave crushing of kidney stones | 28 | $14,131 | $442 |
| Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope | 21 | $12,190 | $580 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 87 | $9,958 | $105 |
| Injection, degarelix, 1 mg | 15 | $8,016 | None |
| Biopsy of prostate gland | 30 | $5,966 | $199 |
| Ultrasound measurement of bladder capacity after voiding | 547 | $5,901 | $8 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 70 | $4,966 | $17 |
| Limited ultrasound scan of pelvis | 122 | $4,631 | $34 |
| Telephone medical discussion with physician, 11-20 minutes | 65 | $4,233 | $59 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 43 | $3,561 | $57 |
| Simple measurement of pressure of urine flow in bladder | 34 | $3,526 | $104 |
| Injection of drug or substance under skin or into muscle | 133 | $3,223 | $11 |
| Return visit (30+ min) | 32 | $2,481 | $73 |
| Ultrasonic guidance for needle placement | 30 | $1,331 | $44 |
| New patient visit (30+ min) | 11 | $878 | $80 |
| Simple timed assessment of bladder emptying | 36 | $239 | $7 |
| Injection, garamycin, gentamicin, up to 80 mg | 88 | $147 | None |
| Electronic assessment of bladder emptying | 16 | $97 | $6 |
| Injection, ketorolac tromethamine, per 15 mg | 15 | $25 | None |
2019: 28 services
| Short return visit (20+ min) | 1,128 | $129,187 | $53 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 45 | $59,698 | None |
| Destruction of prostate tissue using microwave induced heat | 41 | $55,565 | $1,355 |
| Ultrasound scan of pelvic region through rectum | 441 | $48,808 | $98 |
| New patient visit (60+ min) | 191 | $29,710 | $156 |
| Insertion of lower leg neurostimulator electrode | 27 | $26,892 | $107 |
| Dilation of urethra using an endoscope | 83 | $24,015 | $245 |
| Diagnostic exam of bladder and urethra using an endoscope | 121 | $22,300 | $151 |
| Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope | 30 | $17,635 | $588 |
| Long return visit (40+ min) | 124 | $14,539 | $111 |
| Shock wave crushing of kidney stones | 23 | $12,748 | $455 |
| Simple insertion of temporary bladder tube | 53 | $10,700 | $49 |
| Ultrasound measurement of bladder capacity after voiding | 497 | $7,112 | $10 |
| New patient visit (45+ min) | 56 | $6,752 | $121 |
| Limited ultrasound scan of pelvis | 144 | $6,170 | $35 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 48 | $5,986 | $109 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 52 | $4,046 | $17 |
| Biopsy of prostate gland | 19 | $3,961 | $208 |
| Simple measurement of pressure of urine flow in bladder | 33 | $3,514 | $106 |
| Injection of drug or substance under skin or into muscle | 98 | $2,621 | $14 |
| Return visit (30+ min) | 26 | $2,348 | $87 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 23 | $1,819 | $59 |
| Ultrasonic guidance for needle placement | 16 | $756 | $47 |
| Short return visit | 11 | $512 | $37 |
| Simple timed assessment of bladder emptying | 28 | $203 | $7 |
| Electronic assessment of bladder emptying | 31 | $196 | $6 |
| Injection, garamycin, gentamicin, up to 80 mg | 54 | $88 | None |
| Injection, ketorolac tromethamine, per 15 mg | 29 | $20 | None |
2018: 30 services
| Short return visit (20+ min) | 1,231 | $135,924 | $52 |
| Destruction of prostate tissue using microwave induced heat | 41 | $72,120 | $1,759 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 45 | $55,412 | None |
| Ultrasound scan of pelvic region through rectum | 411 | $33,761 | $74 |
| New patient visit (60+ min) | 182 | $28,117 | $154 |
| Dilation of urethra using an endoscope | 99 | $23,591 | $220 |
| Diagnostic exam of bladder and urethra using an endoscope | 134 | $19,048 | $119 |
| Insertion of lower leg neurostimulator electrode | 28 | $18,179 | $104 |
| Long return visit (40+ min) | 138 | $16,737 | $111 |
| Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope | 23 | $13,679 | $595 |
| Simple insertion of temporary bladder tube | 56 | $9,710 | $48 |
| Ultrasound measurement of bladder capacity after voiding | 517 | $9,220 | $13 |
| Shock wave crushing of kidney stones | 15 | $8,158 | $453 |
| Return visit (30+ min) | 86 | $7,601 | $81 |
| Insertion of multicomponent inflatable penile implant | 12 | $7,363 | $614 |
| Simple measurement of pressure of urine flow in bladder | 62 | $6,418 | $104 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 44 | $4,963 | $108 |
| Urinalysis, manual test | 669 | $4,177 | $3 |
| Biopsy of prostate gland | 16 | $3,548 | $209 |
| New patient visit (45+ min) | 29 | $3,527 | $122 |
| Limited ultrasound scan of pelvis | 72 | $3,212 | $37 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 31 | $2,885 | $59 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 40 | $2,620 | $16 |
| Short return visit | 68 | $2,412 | $31 |
| Injection of drug or substance under skin or into muscle | 58 | $2,148 | $17 |
| New patient visit (30+ min) | 11 | $903 | $82 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 32 | $778 | $23 |
| Electronic assessment of bladder emptying | 36 | $275 | $8 |
| Simple timed assessment of bladder emptying | 26 | $166 | $6 |
| Injection, garamycin, gentamicin, up to 80 mg | 15 | $22 | None |
2017: 25 services
| Short return visit (20+ min) | 1,256 | $140,735 | $52 |
| Destruction of prostate tissue using microwave induced heat | 53 | $93,167 | $1,758 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 46 | $64,773 | None |
| Ultrasound scan of pelvic region through rectum | 419 | $34,389 | $72 |
| Dilation of urethra using an endoscope | 115 | $28,350 | $221 |
| New patient visit (60+ min) | 153 | $21,474 | $140 |
| Long return visit (40+ min) | 145 | $17,531 | $110 |
| Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope | 24 | $16,412 | $684 |
| Insertion of lower leg neurostimulator electrode | 22 | $16,093 | $102 |
| Diagnostic exam of bladder and urethra using an endoscope | 111 | $14,564 | $115 |
| Ultrasound measurement of bladder capacity after voiding | 397 | $8,974 | $15 |
| Simple measurement of pressure of urine flow in bladder | 74 | $7,545 | $101 |
| Simple insertion of temporary bladder tube | 37 | $7,238 | $49 |
| Short return visit | 136 | $6,684 | $30 |
| Shock wave crushing of kidney stones | 13 | $6,555 | $468 |
| Return visit (30+ min) | 76 | $6,200 | $78 |
| Urinalysis, manual test | 832 | $5,828 | $3 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 49 | $5,755 | $111 |
| Biopsy of prostate gland | 19 | $3,905 | $206 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 47 | $3,777 | $27 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 27 | $3,164 | $59 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 23 | $3,008 | $15 |
| Limited ultrasound scan of pelvis | 31 | $1,410 | $38 |
| New patient visit (30+ min) | 11 | $795 | $72 |
| Electronic assessment of bladder emptying | 61 | $431 | $7 |
2016: 26 services
| Short return visit (20+ min) | 1,210 | $128,184 | $52 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 45 | $74,952 | None |
| Destruction of prostate tissue using microwave induced heat | 43 | $73,700 | $1,714 |
| Ultrasound scan of pelvic region through rectum | 460 | $36,129 | $70 |
| Dilation of urethra using an endoscope | 144 | $34,530 | $216 |
| New patient visit (60+ min) | 154 | $23,427 | $152 |
| Diagnostic exam of bladder and urethra using an endoscope | 120 | $22,197 | $156 |
| Insertion of lower leg neurostimulator electrode | 21 | $17,726 | $104 |
| Long return visit (40+ min) | 141 | $17,149 | $108 |
| Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope | 22 | $14,833 | $674 |
| Ultrasound measurement of bladder capacity after voiding | 504 | $9,570 | $14 |
| Shock wave crushing of kidney stones | 19 | $9,290 | $442 |
| Short return visit | 178 | $9,266 | $32 |
| Return visit (30+ min) | 117 | $9,231 | $76 |
| Simple insertion of temporary bladder tube | 36 | $8,458 | $54 |
| Urinalysis, manual test | 913 | $6,317 | $3 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 56 | $5,969 | $103 |
| Simple measurement of pressure of urine flow in bladder | 59 | $4,541 | $77 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 46 | $4,015 | $27 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 19 | $3,128 | $16 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 25 | $3,032 | $56 |
| Biopsy of prostate gland | 15 | $2,584 | $172 |
| New patient visit (45+ min) | 16 | $1,851 | $116 |
| New patient visit (30+ min) | 12 | $907 | $76 |
| Electronic assessment of bladder emptying | 50 | $394 | $8 |
| Simple timed assessment of bladder emptying | 24 | $164 | $7 |
2015: 31 services
| Short return visit (20+ min) | 1,249 | $149,660 | $54 |
| Destruction of prostate tissue using microwave induced heat | 55 | $94,066 | $1,710 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 47 | $72,155 | None |
| Ultrasound scan of pelvic region through rectum | 468 | $37,881 | $72 |
| Diagnostic exam of bladder and urethra using an endoscope | 160 | $31,274 | $165 |
| Dilation of urethra using an endoscope | 128 | $30,479 | $218 |
| New patient visit (60+ min) | 184 | $29,097 | $158 |
| Injection, testosterone undecanoate, 1 mg | 11 | $23,590 | None |
| Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope | 29 | $19,690 | $679 |
| Long return visit (40+ min) | 130 | $15,714 | $112 |
| Insertion of lower leg neurostimulator electrode | 18 | $14,445 | $97 |
| Ultrasound measurement of bladder capacity after voiding | 623 | $13,593 | $15 |
| Shock wave crushing of kidney stones | 17 | $11,173 | $447 |
| Simple insertion of temporary bladder tube | 48 | $10,679 | $55 |
| Return visit (30+ min) | 115 | $9,719 | $81 |
| Creation of sling around urethra in female to control leakage | 15 | $8,681 | $579 |
| Short return visit | 183 | $8,325 | $33 |
| Urinalysis, manual test | 973 | $7,142 | $3 |
| Simple measurement of pressure of urine flow in bladder | 84 | $6,649 | $78 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 42 | $4,591 | $107 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 46 | $3,753 | $27 |
| Imaging of urinary tract using infusion technique with kidney section filming | 23 | $2,791 | $112 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 26 | $2,557 | $58 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 27 | $2,517 | $15 |
| X-ray of abdomen, single view | 68 | $2,015 | $19 |
| Biopsy of prostate gland | 11 | $1,967 | $179 |
| New patient visit (45+ min) | 11 | $1,409 | $128 |
| Imaging of abdomen | 30 | $1,071 | $27 |
| Electronic assessment of bladder emptying | 117 | $941 | $8 |
| Injection of drug or substance under skin or into muscle | 11 | $714 | $20 |
| Ultrasonic guidance for needle placement | 11 | $546 | $50 |
2014: 31 services
| Short return visit (20+ min) | 1,281 | $155,620 | $54 |
| Destruction of prostate tissue using microwave induced heat | 63 | $108,269 | $1,719 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 55 | $79,975 | None |
| Ultrasound scan of pelvic region through rectum | 467 | $36,668 | $71 |
| Diagnostic exam of bladder and urethra using an endoscope | 156 | $31,226 | $159 |
| New patient visit (60+ min) | 188 | $29,452 | $157 |
| Dilation of urethra using an endoscope | 114 | $27,755 | $217 |
| Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope | 23 | $15,658 | $681 |
| Ultrasound measurement of bladder capacity after voiding | 737 | $15,414 | $15 |
| Long return visit (40+ min) | 115 | $14,335 | $112 |
| Insertion of lower leg neurostimulator electrode | 15 | $13,749 | $97 |
| Simple insertion of temporary bladder tube | 45 | $12,104 | $56 |
| Shock wave crushing of kidney stones | 16 | $8,398 | $442 |
| Short return visit | 175 | $7,859 | $33 |
| Return visit (30+ min) | 80 | $6,903 | $83 |
| Insertion of multicomponent inflatable penile implant | 11 | $6,524 | $544 |
| Creation of sling around urethra in female to control leakage | 11 | $6,402 | $582 |
| Urinalysis, manual test | 851 | $5,875 | $3 |
| Simple measurement of pressure of urine flow in bladder | 66 | $5,342 | $81 |
| Imaging of urinary tract using infusion technique with kidney section filming | 36 | $4,652 | $116 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 41 | $4,540 | $111 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 57 | $4,477 | $27 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 39 | $4,129 | $15 |
| X-ray of abdomen, single view | 83 | $2,509 | $20 |
| Biopsy of prostate gland | 14 | $2,494 | $178 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 23 | $1,952 | $57 |
| Manual urinalysis test with examination using microscope, non-automated | 292 | $1,739 | $4 |
| New patient visit (45+ min) | 11 | $1,376 | $125 |
| Electronic assessment of bladder emptying | 131 | $1,202 | $9 |
| Ultrasonic guidance for needle placement | 13 | $759 | $58 |
| Imaging of abdomen | 12 | $464 | $33 |
2013: 33 services
| Short return visit (20+ min) | 1,270 | $158,656 | $54 |
| Destruction of prostate tissue using microwave induced heat | 48 | $84,585 | $1,762 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 58 | $84,578 | None |
| Dilation of urethra using an endoscope | 136 | $32,421 | $219 |
| Diagnostic exam of bladder and urethra using an endoscope | 157 | $31,722 | $159 |
| New patient visit (60+ min) | 177 | $26,950 | $152 |
| Ultrasound scan of pelvic region through rectum | 345 | $22,365 | $58 |
| Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope | 32 | $20,884 | $653 |
| Ultrasound measurement of bladder capacity after voiding | 841 | $19,069 | $15 |
| Long return visit (40+ min) | 146 | $18,168 | $113 |
| Simple insertion of temporary bladder tube | 62 | $11,990 | $57 |
| Insertion of lower leg neurostimulator electrode | 14 | $11,246 | $103 |
| Manual urinalysis test with examination using microscope, non-automated | 1,044 | $9,918 | $4 |
| Short return visit | 183 | $8,875 | $34 |
| Return visit (30+ min) | 100 | $8,576 | $82 |
| Creation of sling around urethra in female to control leakage | 15 | $8,536 | $569 |
| Shock wave crushing of kidney stones | 15 | $8,128 | $452 |
| Simple measurement of pressure of urine flow in bladder | 80 | $6,506 | $79 |
| Insertion of multicomponent inflatable penile implant | 12 | $6,096 | $508 |
| Psa (prostate specific antigen) measurement, total | 238 | $5,910 | $25 |
| Imaging of urinary tract using infusion technique with kidney section filming | 43 | $5,037 | $117 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 60 | $4,995 | $27 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 35 | $4,440 | $16 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 32 | $3,450 | $108 |
| Biopsy of prostate gland | 15 | $2,661 | $177 |
| X-ray of abdomen, single view | 92 | $2,622 | $19 |
| Destruction and/or removal of growth of bladder and urethra using an endoscope, 2.0-5.0 cm | 12 | $2,600 | $173 |
| Ultrasonic guidance for needle placement | 15 | $2,593 | $173 |
| Electronic assessment of bladder emptying | 234 | $2,574 | $10 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 25 | $2,486 | $56 |
| Imaging of urinary tract using infusion technique | 11 | $1,162 | $97 |
| Limited ultrasound scan of pelvis | 11 | $752 | $68 |
| Imaging of abdomen | 16 | $566 | $33 |
Medicaid work
$421,854 in 2024
Medicaid paid $421,854 for 5,443 billed services this clinician did in 2024, up to 159 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 2,310 | $391,935 |
| Short return visit (20+ min) | 1,327 | $20,971 |
| Ultrasound, transrectal | 56 | $5,461 |
| CYSTOURETHROSCOPY | 12 | $2,673 |
| Measurement of post-voiding residual urine and/or bladder capacity by ultrasound, non-imaging | 113 | $694 |
| Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular | 458 | $119 |
| New patient visit (45+ min) | 353 | $0 |
| Short return visit | 374 | $0 |
| Injection, testosterone cypionate, 1 mg | 440 | $0 |
| 2024 | 5,443 | 9 | 159 | $421,854 |
| 2023 | 6,045 | 13 | 171 | $437,231 |
| 2022 | 5,796 | 15 | 187 | $411,616 |
| 2021 | 6,891 | 16 | 176 | $541,758 |
| 2020 | 4,116 | 12 | 124 | $390,651 |
| 2019 | 3,127 | 9 | 98 | $297,508 |
| 2018 | 3,351 | 9 | 107 | $260,092 |
See the largest Medicaid services in earlier years
2023
| Clinic visit/encounter, all-inclusive | 2,170 | $382,488 |
| Short return visit (20+ min) | 1,894 | $33,997 |
| Ultrasound, transrectal | 114 | $7,301 |
| Complex cystometrogram (ie, calibrated electronic equipment); with voiding pressure studies (ie, bladder voiding pressure), any technique | 30 | $4,636 |
| CYSTOSCOPY AND TREATMENT | 14 | $3,295 |
| Insertion of temporary indwelling bladder catheter; simple (eg, Foley) | 87 | $2,502 |
| Measurement of post-voiding residual urine and/or bladder capacity by ultrasound, non-imaging | 495 | $1,582 |
| ANAL/URINARY MUSCLE STUDY | 34 | $1,176 |
| Complex uroflowmetry (eg, calibrated electronic equipment) | 34 | $255 |
| Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular | 301 | $0 |
| New patient visit (45+ min) | 301 | $0 |
| Short return visit | 271 | $0 |
2022
| Clinic visit/encounter, all-inclusive | 1,860 | $347,722 |
| Short return visit (20+ min) | 2,023 | $28,666 |
| Ultrasound, transrectal | 189 | $9,898 |
| Complex cystometrogram (ie, calibrated electronic equipment); with voiding pressure studies (ie, bladder voiding pressure), any technique | 40 | $6,714 |
| Long return visit (40+ min) | 79 | $6,643 |
| New patient visit (45+ min) | 390 | $4,411 |
| ANAL/URINARY MUSCLE STUDY | 82 | $1,951 |
| Insertion of temporary indwelling bladder catheter; simple (eg, Foley) | 103 | $1,745 |
| 1ST HOSPITAL IP/OBS CARE MODERATE MDM 55 MINUTES | 26 | $1,725 |
| Measurement of post-voiding residual urine and/or bladder capacity by ultrasound, non-imaging | 527 | $1,298 |
| Complex uroflowmetry (eg, calibrated electronic equipment) | 72 | $427 |
| Urinary leg bag | 12 | $415 |
2021
| Clinic visit/encounter, all-inclusive | 2,456 | $430,998 |
| Short return visit (20+ min) | 2,373 | $57,087 |
| New patient visit (45+ min) | 552 | $24,301 |
| Ultrasound, transrectal | 189 | $8,323 |
| 1ST HOSPITAL IP/OBS CARE MODERATE MDM 55 MINUTES | 55 | $5,097 |
| CYSTOSCOPY AND TREATMENT | 15 | $3,575 |
| Insertion of temporary indwelling bladder catheter; simple (eg, Foley) | 131 | $3,384 |
| CYSTOURETHROSCOPY | 13 | $2,258 |
| Long return visit (40+ min) | 26 | $1,947 |
| Short return visit | 129 | $1,353 |
| Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular | 269 | $1,224 |
| New patient visit (30+ min) | 24 | $889 |
2020
| Clinic visit/encounter, all-inclusive | 1,890 | $318,262 |
| Short return visit (20+ min) | 1,419 | $47,309 |
| New patient visit (45+ min) | 118 | $10,951 |
| Ultrasound, transrectal | 196 | $5,397 |
| Insertion of temporary indwelling bladder catheter; simple (eg, Foley) | 129 | $3,481 |
| 1ST HOSPITAL IP/OBS CARE MODERATE MDM 55 MINUTES | 27 | $1,986 |
| CYSTOURETHROSCOPY | 12 | $1,070 |
| Measurement of post-voiding residual urine and/or bladder capacity by ultrasound, non-imaging | 254 | $858 |
| Long return visit (40+ min) | 13 | $665 |
| Short return visit | 27 | $555 |
| OFF/OP EST MAY X REQ PHY/QHP | 15 | $116 |
| Hospital outpatient clinic visit for assessment and management of a patient | 16 | $0 |
2019
| Clinic visit/encounter, all-inclusive | 1,477 | $241,511 |
| Short return visit (20+ min) | 1,169 | $44,596 |
| Ultrasound, transrectal | 151 | $3,429 |
| CYSTOSCOPY AND TREATMENT | 13 | $2,026 |
| New patient visit (45+ min) | 12 | $1,966 |
| 1ST HOSPITAL IP/OBS CARE MODERATE MDM 55 MINUTES | 12 | $1,203 |
| X-ray of abdomen, 1 view | 43 | $1,167 |
| Long return visit (40+ min) | 24 | $1,027 |
| Measurement of post-voiding residual urine and/or bladder capacity by ultrasound, non-imaging | 226 | $583 |
2018
| Clinic visit/encounter, all-inclusive | 1,500 | $212,861 |
| Short return visit (20+ min) | 999 | $31,798 |
| CYSTOSCOPY AND TREATMENT | 45 | $7,180 |
| SIMPLE CYSTOMETROGRAM | 26 | $3,020 |
| New patient visit (45+ min) | 13 | $2,140 |
| Ultrasound, transrectal | 77 | $1,047 |
| CYSTOURETHROSCOPY | 13 | $796 |
| Measurement of post-voiding residual urine and/or bladder capacity by ultrasound, non-imaging | 208 | $790 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; non-automated, without microscopy | 470 | $461 |
Drugs they prescribed that Part D paid
$1,377,485
Pharmacies billed $1,377,485 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 2% of their Part D prescriptions (146 of 6,115) in 2024. Above the middle of the specialty; the typical urology clinician is at 2%.
5,275 generic and fewer than 11 brand-name prescriptions · $1,377,485 in drug cost · 893 antibiotic prescriptions to 401 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Xtandi | 32 | $458,724 | $14,335 |
| Myrbetriq | 461 | $445,218 | $966 |
| Gemtesa | 269 | $285,726 | $1,062 |
| Tamsulosin | 1,690 | $31,641 | $19 |
| Finasteride | 753 | $13,039 | $17 |
See all 42 drugs
| Xtandi | 32 | $458,724 | $14,335 |
| Myrbetriq | 461 | $445,218 | $966 |
| Gemtesa | 269 | $285,726 | $1,062 |
| Tamsulosin | 1,690 | $31,641 | $19 |
| Finasteride | 753 | $13,039 | $17 |
| Oxybutynin Chloride Er | 403 | $11,083 | $28 |
| Nitrofurantoin | 197 | $8,296 | $42 |
| Testosterone Cypionate | 199 | $7,787 | $39 |
| Mirabegron Er | 11 | $6,585 | $599 |
| Solifenacin | 84 | $6,217 | $74 |
| Testosterone | 21 | $6,147 | $293 |
| Desmopressin Acetate | 78 | $4,490 | $58 |
| Dutasteride | 62 | $4,302 | $69 |
| Fesoterodine Fumarate Er | 18 | $3,302 | $183 |
| Tolterodine Tartrate Er | 14 | $2,934 | $210 |
| Tadalafil | 32 | $2,830 | $88 |
| Estradiol | 40 | $2,750 | $69 |
| Cephalexin | 212 | $2,294 | $11 |
| Sulfamethoxazole-Trimethoprim | 242 | $2,041 | $8 |
| Doxazosin Mesylate | 125 | $1,871 | $15 |
| Potassium Citrate Er | 17 | $1,743 | $103 |
| Nystatin | 139 | $1,728 | $12 |
| Trospium Chloride | 13 | $1,316 | $101 |
| Terazosin | 47 | $922 | $20 |
| Nitrofurantoin Mono-Macro | 45 | $765 | $17 |
| Ciprofloxacin | 113 | $758 | $7 |
| Alfuzosin Hcl Er | 39 | $722 | $19 |
| Hydrocodone-Acetaminophen | 76 | $682 | $9 |
| Triamcinolone Acetonide | 139 | $655 | $5 |
| Nystatin-Triamcinolone | 13 | $612 | $47 |
| Amoxicillin-Clavulanate Potass | 42 | $526 | $13 |
| Sildenafil Citrate | 53 | $524 | $10 |
| Oxybutynin Chloride | 23 | $483 | $21 |
| Bicalutamide | 16 | $474 | $30 |
| Levofloxacin | 33 | $362 | $11 |
| Allopurinol | 33 | $323 | $10 |
| Ibuprofen | 69 | $262 | $4 |
| Fluconazole | 36 | $256 | $7 |
| Potassium Chloride | 13 | $224 | $17 |
| Tramadol | 58 | $133 | $2 |
| Hydrochlorothiazide | 11 | $90 | $8 |
| Lorazepam | 13 | $26 | $2 |
Year by year
| 2024 | 6,115 | 1,322 | 2% (146) | None | $1,377,485 |
| 2023 | 6,757 | 1,510 | 3% (180) | None | $1,128,766 |
| 2022 | 7,505 | 1,536 | 3% (219) | None | $1,124,798 |
| 2021 | 7,463 | 1,274 | 2% (169) | None | $1,017,466 |
| 2020 | 6,734 | 1,096 | 3% (207) | None | $810,016 |
| 2019 | 5,887 | 945 | 4% (216) | None | $766,011 |
| 2018 | 5,509 | 873 | 3% (160) | None | $639,452 |
| 2017 | 5,453 | 780 | 3% (177) | 25% | $563,228 |
| 2016 | 4,813 | 731 | 4% (186) | None | $453,079 |
| 2015 | 4,578 | 700 | 4% (194) | None | $405,542 |
| 2014 | 3,960 | 643 | 4% (162) | None | $343,173 |
| 2013 | 3,471 | 609 | 5% (155) | 33% | $279,714 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 43 drugs
| Myrbetriq | 618 | $617,979 | $1,000 |
| Xtandi | 12 | $181,359 | $15,113 |
| Gemtesa | 76 | $81,547 | $1,073 |
| Tamsulosin | 1,895 | $61,757 | $33 |
| Oxybutynin Chloride Er | 440 | $26,362 | $60 |
| Finasteride | 901 | $21,769 | $24 |
| Solifenacin | 70 | $17,603 | $251 |
| Nitrofurantoin | 237 | $11,216 | $47 |
| Testosterone | 26 | $10,558 | $406 |
| Fesoterodine Fumarate Er | 34 | $8,310 | $244 |
| Tolterodine Tartrate Er | 19 | $7,372 | $388 |
| Testosterone Cypionate | 200 | $7,024 | $35 |
| Desmopressin Acetate | 74 | $6,906 | $93 |
| Dutasteride | 91 | $6,239 | $69 |
| Cephalexin | 219 | $4,622 | $21 |
| Doxazosin Mesylate | 149 | $4,207 | $28 |
| Estradiol | 32 | $3,467 | $108 |
| Sulfamethoxazole-Trimethoprim | 273 | $2,897 | $11 |
| Trospium Chloride | 30 | $2,858 | $95 |
| Ciprofloxacin | 197 | $2,455 | $12 |
| Tadalafil | 23 | $2,411 | $105 |
| Bicalutamide | 47 | $2,034 | $43 |
| Nystatin | 141 | $2,007 | $14 |
| Potassium Citrate Er | 17 | $1,538 | $90 |
| Bethanechol Chloride | 17 | $1,381 | $81 |
| Hydrocodone-Acetaminophen | 111 | $1,319 | $12 |
| Terazosin | 55 | $1,246 | $23 |
| Oxybutynin Chloride | 38 | $1,202 | $32 |
| Alfuzosin Hcl Er | 25 | $1,041 | $42 |
| Triamcinolone Acetonide | 146 | $970 | $7 |
| Nitrofurantoin Mono-Macro | 45 | $936 | $21 |
| Imipramine | 18 | $755 | $42 |
| Potassium Chloride | 17 | $559 | $33 |
| Levofloxacin | 26 | $478 | $18 |
| Allopurinol | 34 | $416 | $12 |
| Amoxicillin-Clavulanate Potass | 31 | $414 | $13 |
| Fluconazole | 30 | $333 | $11 |
| Ibuprofen | 69 | $292 | $4 |
| Sildenafil Citrate | 41 | $187 | $5 |
| Acetaminophen-Codeine | 41 | $151 | $4 |
| Sodium Chloride | 12 | $109 | $9 |
| Tramadol | 28 | $70 | $2 |
| Hydrochlorothiazide | 13 | $45 | $3 |
2022: 43 drugs
| Myrbetriq | 839 | $560,990 | $669 |
| Xtandi | 21 | $304,422 | $14,496 |
| Tamsulosin | 2,085 | $43,007 | $21 |
| Gemtesa | 43 | $32,401 | $754 |
| Oxybutynin Chloride Er | 635 | $32,271 | $51 |
| Finasteride | 954 | $17,669 | $19 |
| Nitrofurantoin | 292 | $12,518 | $43 |
| Toviaz | 22 | $11,283 | $513 |
| Desmopressin Acetate | 121 | $10,940 | $90 |
| Tolterodine Tartrate Er | 39 | $9,079 | $233 |
| Testosterone | 14 | $8,586 | $613 |
| Solifenacin | 66 | $8,334 | $126 |
| Testosterone Cypionate | 167 | $7,884 | $47 |
| Trospium Chloride | 55 | $6,102 | $111 |
| Estradiol | 29 | $3,711 | $128 |
| Potassium Citrate Er | 35 | $3,547 | $101 |
| Sulfamethoxazole-Trimethoprim | 341 | $3,224 | $9 |
| Tadalafil | 26 | $3,196 | $123 |
| Cephalexin | 242 | $2,734 | $11 |
| Dutasteride | 33 | $2,546 | $77 |
| Doxazosin Mesylate | 130 | $2,542 | $20 |
| Ciprofloxacin | 201 | $2,206 | $11 |
| Nystatin | 117 | $2,105 | $18 |
| Fesoterodine Fumarate Er | 15 | $2,047 | $136 |
| Nitrofurantoin Mono-Macro | 52 | $1,708 | $33 |
| Bicalutamide | 35 | $1,441 | $41 |
| Nystatin-Triamcinolone | 27 | $1,301 | $48 |
| Terazosin | 52 | $1,137 | $22 |
| Alfuzosin Hcl Er | 33 | $1,094 | $33 |
| Bethanechol Chloride | 12 | $967 | $81 |
| Triamcinolone Acetonide | 118 | $841 | $7 |
| Hydrocodone-Acetaminophen | 88 | $759 | $9 |
| Allopurinol | 42 | $755 | $18 |
| Acetaminophen-Codeine | 123 | $673 | $5 |
| Imipramine | 20 | $561 | $28 |
| Fluconazole | 39 | $472 | $12 |
| Levofloxacin | 23 | $356 | $15 |
| Oxybutynin Chloride | 12 | $315 | $26 |
| Ibuprofen | 66 | $291 | $4 |
| Amoxicillin-Clavulanate Potass | 17 | $253 | $15 |
| Sildenafil Citrate | 18 | $244 | $14 |
| Hydrochlorothiazide | 19 | $31 | $2 |
| Lorazepam | 14 | $24 | $2 |
2021: 38 drugs
| Myrbetriq | 1,069 | $561,172 | $525 |
| Xtandi | 19 | $251,709 | $13,248 |
| Oxybutynin Chloride Er | 842 | $37,911 | $45 |
| Tamsulosin | 1,937 | $28,757 | $15 |
| Toviaz | 52 | $23,436 | $451 |
| Finasteride | 970 | $16,507 | $17 |
| Nitrofurantoin | 299 | $10,486 | $35 |
| Desmopressin Acetate | 191 | $9,762 | $51 |
| Tolterodine Tartrate Er | 56 | $7,698 | $137 |
| Solifenacin | 43 | $6,995 | $163 |
| Trospium Chloride | 70 | $5,421 | $77 |
| Testosterone Cypionate | 81 | $5,077 | $63 |
| Potassium Citrate Er | 32 | $3,781 | $118 |
| Sulfamethoxazole-Trimethoprim | 317 | $3,023 | $10 |
| Estradiol | 21 | $2,757 | $131 |
| Doxazosin Mesylate | 106 | $2,086 | $20 |
| Dutasteride | 29 | $2,058 | $71 |
| Bicalutamide | 54 | $2,026 | $38 |
| Cephalexin | 213 | $1,906 | $9 |
| Nitrofurantoin Mono-Macro | 57 | $1,762 | $31 |
| Ciprofloxacin | 148 | $1,518 | $10 |
| Bethanechol Chloride | 14 | $1,514 | $108 |
| Nystatin | 82 | $1,443 | $18 |
| Nystatin-Triamcinolone | 19 | $1,344 | $71 |
| Alfuzosin Hcl Er | 41 | $1,150 | $28 |
| Terazosin | 44 | $877 | $20 |
| Acetaminophen-Codeine | 105 | $827 | $8 |
| Allopurinol | 38 | $805 | $21 |
| Hydrocodone-Acetaminophen | 47 | $765 | $16 |
| Triamcinolone Acetonide | 88 | $703 | $8 |
| Tadalafil | 11 | $359 | $33 |
| Levofloxacin | 23 | $354 | $15 |
| Fluconazole | 35 | $316 | $9 |
| Imipramine | 19 | $231 | $12 |
| Ibuprofen | 52 | $173 | $3 |
| Amoxicillin-Clavulanate Potass | 12 | $131 | $11 |
| Hydrochlorothiazide | 12 | $64 | $5 |
| Lorazepam | 17 | $15 | $1 |
2020: 38 drugs
| Myrbetriq | 973 | $483,349 | $497 |
| Xtandi | 11 | $138,307 | $12,573 |
| Oxybutynin Chloride Er | 720 | $32,026 | $44 |
| Toviaz | 69 | $27,271 | $395 |
| Tamsulosin | 1,617 | $20,911 | $13 |
| Finasteride | 802 | $13,147 | $16 |
| Nitrofurantoin | 338 | $11,367 | $34 |
| Solifenacin | 70 | $8,568 | $122 |
| Trospium Chloride | 53 | $6,964 | $131 |
| Desmopressin Acetate | 159 | $6,028 | $38 |
| Testosterone Cypionate | 112 | $5,979 | $53 |
| Testosterone | 14 | $5,622 | $402 |
| Tolterodine Tartrate Er | 42 | $4,640 | $110 |
| Bethanechol Chloride | 21 | $4,344 | $207 |
| Potassium Citrate Er | 22 | $2,044 | $93 |
| Sulfamethoxazole-Trimethoprim | 287 | $1,978 | $7 |
| Nystatin | 111 | $1,827 | $16 |
| Doxazosin Mesylate | 97 | $1,769 | $18 |
| Dutasteride | 37 | $1,728 | $47 |
| Bicalutamide | 44 | $1,607 | $37 |
| Nitrofurantoin Mono-Macro | 63 | $1,250 | $20 |
| Terazosin | 56 | $1,080 | $19 |
| Cephalexin | 144 | $1,078 | $7 |
| Allopurinol | 57 | $1,055 | $19 |
| Hydrocodone-Acetaminophen | 72 | $945 | $13 |
| Triamcinolone Acetonide | 107 | $862 | $8 |
| Ciprofloxacin | 120 | $808 | $7 |
| Acetaminophen-Codeine | 105 | $767 | $7 |
| Alfuzosin Hcl Er | 29 | $669 | $23 |
| Fluconazole | 30 | $667 | $22 |
| Nystatin-Triamcinolone | 19 | $609 | $32 |
| Imipramine | 49 | $589 | $12 |
| Levofloxacin | 24 | $489 | $20 |
| Amoxicillin-Clavulanate Potass | 14 | $290 | $21 |
| Tadalafil | 11 | $162 | $15 |
| Ibuprofen | 40 | $130 | $3 |
| Tramadol | 21 | $91 | $4 |
| Hydrochlorothiazide | 27 | $80 | $3 |
2019: 40 drugs
| Myrbetriq | 782 | $367,395 | $470 |
| Xtandi | 14 | $172,998 | $12,357 |
| Vesicare | 95 | $44,204 | $465 |
| Toviaz | 82 | $34,865 | $425 |
| Oxybutynin Chloride Er | 553 | $23,619 | $43 |
| Tamsulosin | 1,412 | $18,906 | $13 |
| Finasteride | 623 | $10,132 | $16 |
| Solifenacin | 82 | $9,135 | $111 |
| Trospium Chloride | 66 | $7,570 | $115 |
| Tolterodine Tartrate Er | 43 | $6,916 | $161 |
| Testosterone | 17 | $6,718 | $395 |
| Testosterone Cypionate | 111 | $5,754 | $52 |
| Nitrofurantoin | 164 | $4,845 | $30 |
| Desmopressin Acetate | 145 | $4,838 | $33 |
| Bethanechol Chloride | 16 | $3,395 | $212 |
| Dutasteride | 60 | $3,310 | $55 |
| Tadalafil | 11 | $3,263 | $297 |
| Sulfamethoxazole-Trimethoprim | 203 | $1,627 | $8 |
| Potassium Citrate Er | 22 | $1,564 | $71 |
| Ciprofloxacin | 210 | $1,547 | $7 |
| Nystatin | 104 | $1,471 | $14 |
| Nitrofurantoin Mono-Macro | 56 | $1,389 | $25 |
| Bicalutamide | 55 | $1,375 | $25 |
| Doxazosin Mesylate | 58 | $1,278 | $22 |
| Imipramine | 43 | $1,260 | $29 |
| Levofloxacin | 27 | $1,112 | $41 |
| Allopurinol | 49 | $1,062 | $22 |
| Cephalexin | 99 | $817 | $8 |
| Hydrocodone-Acetaminophen | 65 | $748 | $12 |
| Triamcinolone Acetonide | 104 | $700 | $7 |
| Acetaminophen-Codeine | 140 | $593 | $4 |
| Amitriptyline | 14 | $556 | $40 |
| Alfuzosin Hcl Er | 19 | $477 | $25 |
| Terazosin | 43 | $421 | $10 |
| Fluconazole | 15 | $361 | $24 |
| Ibuprofen | 50 | $183 | $4 |
| Hydrochlorothiazide | 28 | $80 | $3 |
| Metformin | 11 | $57 | $5 |
| Lorazepam | 42 | $46 | $1 |
| Ketorolac Tromethamine | 15 | $37 | $2 |
2018: 36 drugs
| Myrbetriq | 746 | $331,755 | $445 |
| Vesicare | 210 | $92,474 | $440 |
| Toviaz | 103 | $36,867 | $358 |
| Oxybutynin Chloride Er | 539 | $26,048 | $48 |
| Tamsulosin | 1,229 | $20,963 | $17 |
| Tolterodine Tartrate Er | 60 | $8,251 | $138 |
| Finasteride | 518 | $7,980 | $15 |
| Desmopressin Acetate | 152 | $4,809 | $32 |
| Premarin | 13 | $4,675 | $360 |
| Testosterone Cypionate | 77 | $4,161 | $54 |
| Nitrofurantoin | 127 | $3,759 | $30 |
| Bethanechol Chloride | 14 | $2,788 | $199 |
| Dutasteride | 63 | $2,702 | $43 |
| Nystatin | 125 | $2,416 | $19 |
| Trospium Chloride | 21 | $2,005 | $95 |
| Doxazosin Mesylate | 68 | $1,735 | $26 |
| Ciprofloxacin | 222 | $1,571 | $7 |
| Nitrofurantoin Mono-Macro | 62 | $1,562 | $25 |
| Potassium Citrate Er | 15 | $1,476 | $98 |
| Sulfamethoxazole-Trimethoprim | 209 | $1,287 | $6 |
| Bicalutamide | 65 | $1,053 | $16 |
| Cephalexin | 122 | $934 | $8 |
| Allopurinol | 69 | $919 | $13 |
| Levofloxacin | 31 | $786 | $25 |
| Imipramine | 42 | $780 | $19 |
| Triamcinolone Acetonide | 126 | $733 | $6 |
| Hydrocodone-Acetaminophen | 63 | $682 | $11 |
| Alfuzosin Hcl Er | 27 | $532 | $20 |
| Acetaminophen-Codeine | 84 | $304 | $4 |
| Terazosin | 30 | $228 | $8 |
| Ibuprofen | 48 | $136 | $3 |
| Ketorolac Tromethamine | 13 | $96 | $7 |
| Lorazepam | 43 | $78 | $2 |
| Tramadol | 12 | $53 | $4 |
| Ibu | 11 | $39 | $4 |
| Hydrochlorothiazide | 11 | $39 | $4 |
2017: 37 drugs
| Myrbetriq | 706 | $275,446 | $390 |
| Vesicare | 347 | $131,192 | $378 |
| Oxybutynin Chloride Er | 558 | $28,068 | $50 |
| Toviaz | 62 | $22,301 | $360 |
| Tamsulosin | 1,088 | $20,090 | $18 |
| Estrace | 26 | $7,557 | $291 |
| Tolterodine Tartrate Er | 54 | $7,179 | $133 |
| Finasteride | 518 | $6,565 | $13 |
| Nitrofurantoin | 171 | $5,888 | $34 |
| Testosterone Cypionate | 100 | $4,195 | $42 |
| Bethanechol Chloride | 20 | $3,974 | $199 |
| Desmopressin Acetate | 89 | $3,165 | $36 |
| Trospium Chloride Er | 19 | $2,734 | $144 |
| Rapaflo | 12 | $2,725 | $227 |
| Dutasteride | 76 | $2,169 | $29 |
| Sulfamethoxazole-Trimethoprim | 251 | $1,594 | $6 |
| Doxazosin Mesylate | 85 | $1,546 | $18 |
| Ciprofloxacin | 233 | $1,529 | $7 |
| Dutasteride-Tamsulosin | 12 | $1,483 | $124 |
| Nystatin | 96 | $1,389 | $14 |
| Nitrofurantoin Mono-Macro | 54 | $1,250 | $23 |
| Trospium Chloride | 17 | $1,195 | $70 |
| Imipramine | 38 | $864 | $23 |
| Cephalexin | 110 | $782 | $7 |
| Oxybutynin Chloride | 16 | $665 | $42 |
| Triamcinolone Acetonide | 104 | $630 | $6 |
| Hydrocodone-Acetaminophen | 75 | $629 | $8 |
| Allopurinol | 53 | $552 | $10 |
| Bicalutamide | 41 | $547 | $13 |
| Acetaminophen-Codeine | 99 | $348 | $4 |
| Terazosin | 41 | $229 | $6 |
| Sodium Chloride | 15 | $185 | $12 |
| Levofloxacin | 18 | $171 | $10 |
| Ibuprofen | 46 | $138 | $3 |
| Ketorolac Tromethamine | 23 | $118 | $5 |
| Lorazepam | 49 | $86 | $2 |
| Ibu | 18 | $51 | $3 |
2016: 36 drugs
| Myrbetriq | 457 | $159,264 | $348 |
| Vesicare | 391 | $130,178 | $333 |
| Toviaz | 121 | $33,195 | $274 |
| Oxybutynin Chloride Er | 402 | $19,507 | $49 |
| Tamsulosin | 882 | $19,243 | $22 |
| Tolterodine Tartrate Er | 68 | $11,940 | $176 |
| Finasteride | 469 | $5,483 | $12 |
| Trospium Chloride Er | 38 | $5,300 | $139 |
| Estrace | 19 | $5,078 | $267 |
| Testosterone Cypionate | 87 | $5,004 | $58 |
| Nitrofurantoin | 151 | $4,690 | $31 |
| Rapaflo | 22 | $4,576 | $208 |
| Desmopressin Acetate | 74 | $3,140 | $42 |
| Avodart | 18 | $3,134 | $174 |
| Ciprofloxacin | 304 | $2,353 | $8 |
| Dutasteride | 65 | $2,245 | $35 |
| Trospium Chloride | 24 | $1,869 | $78 |
| Nystatin | 82 | $1,414 | $17 |
| Sulfamethoxazole-Trimethoprim | 209 | $1,404 | $7 |
| Doxazosin Mesylate | 66 | $1,262 | $19 |
| Imipramine | 48 | $1,061 | $22 |
| Allopurinol | 65 | $1,058 | $16 |
| Bethanechol Chloride | 12 | $972 | $81 |
| Hydrocodone-Acetaminophen | 80 | $951 | $12 |
| Nitrofurantoin Mono-Macro | 31 | $851 | $27 |
| Triamcinolone Acetonide | 105 | $717 | $7 |
| Cephalexin | 52 | $499 | $10 |
| Bicalutamide | 28 | $422 | $15 |
| Acetaminophen-Codeine | 95 | $421 | $4 |
| Fluconazole | 12 | $307 | $26 |
| Terazosin | 29 | $249 | $9 |
| Sodium Chloride | 14 | $173 | $12 |
| Ibuprofen | 54 | $164 | $3 |
| Levofloxacin | 21 | $114 | $5 |
| Lorazepam | 38 | $70 | $2 |
| Ketorolac Tromethamine | 15 | $56 | $4 |
2015: 41 drugs
| Myrbetriq | 324 | $102,246 | $316 |
| Vesicare | 360 | $101,449 | $282 |
| Toviaz | 133 | $32,159 | $242 |
| Tamsulosin | 807 | $22,661 | $28 |
| Oxybutynin Chloride Er | 374 | $21,762 | $58 |
| Avodart | 111 | $20,863 | $188 |
| Tolterodine Tartrate Er | 66 | $13,272 | $201 |
| Androgel | 20 | $12,271 | $614 |
| Premarin | 46 | $11,666 | $254 |
| Rapaflo | 45 | $8,053 | $179 |
| Trospium Chloride Er | 46 | $6,896 | $150 |
| Finasteride | 394 | $5,050 | $13 |
| Desmopressin Acetate | 111 | $5,010 | $45 |
| Testosterone Cypionate | 73 | $3,957 | $54 |
| Nitrofurantoin | 124 | $3,451 | $28 |
| Jalyn | 20 | $3,249 | $162 |
| Gelnique | 11 | $2,961 | $269 |
| Trospium Chloride | 24 | $2,505 | $104 |
| Ciprofloxacin | 313 | $2,397 | $8 |
| Nystatin | 103 | $1,955 | $19 |
| Bethanechol Chloride | 20 | $1,837 | $92 |
| Dutasteride | 14 | $1,808 | $129 |
| Imipramine | 60 | $1,800 | $30 |
| Nitrofurantoin Mono-Macro | 52 | $1,654 | $32 |
| Doxazosin Mesylate | 49 | $1,038 | $21 |
| Hydrocodone-Acetaminophen | 82 | $899 | $11 |
| Sulfamethoxazole-Trimethoprim | 149 | $832 | $6 |
| Bicalutamide | 35 | $778 | $22 |
| Oxybutynin Chloride | 13 | $653 | $50 |
| Allopurinol | 46 | $643 | $14 |
| Triamcinolone Acetonide | 108 | $632 | $6 |
| Acetaminophen-Codeine | 102 | $439 | $4 |
| Ibuprofen | 73 | $310 | $4 |
| Cephalexin | 48 | $256 | $5 |
| Levofloxacin | 26 | $217 | $8 |
| Fluconazole | 14 | $215 | $15 |
| Terazosin | 27 | $160 | $6 |
| Sodium Chloride | 11 | $121 | $11 |
| Ampicillin Trihydrate | 12 | $63 | $5 |
| Lorazepam | 42 | $60 | $1 |
| Ketorolac Tromethamine | 11 | $12 | $1 |
2014: 40 drugs
| Vesicare | 358 | $86,651 | $242 |
| Myrbetriq | 206 | $57,074 | $277 |
| Avodart | 173 | $29,099 | $168 |
| Toviaz | 139 | $28,484 | $205 |
| Oxybutynin Chloride Er | 376 | $21,117 | $56 |
| Tamsulosin | 633 | $13,031 | $21 |
| Tolterodine Tartrate Er | 58 | $11,844 | $204 |
| Premarin | 44 | $9,446 | $215 |
| Androgel | 19 | $9,252 | $487 |
| Trospium Chloride Er | 53 | $8,801 | $166 |
| Rapaflo | 42 | $6,430 | $153 |
| Enablex | 23 | $4,745 | $206 |
| Nitrofurantoin | 118 | $4,094 | $35 |
| Desmopressin Acetate | 93 | $4,002 | $43 |
| Testosterone Cypionate | 63 | $3,968 | $63 |
| Jalyn | 22 | $3,140 | $143 |
| Nystatin-Triamcinolone | 23 | $2,709 | $118 |
| Gelnique | 12 | $2,635 | $220 |
| Finasteride | 193 | $2,336 | $12 |
| Trospium Chloride | 20 | $2,295 | $115 |
| Ciprofloxacin | 260 | $2,117 | $8 |
| Bicalutamide | 42 | $1,632 | $39 |
| Imipramine | 80 | $1,393 | $17 |
| Nystatin | 55 | $1,140 | $21 |
| Nitrofurantoin Mono-Macro | 36 | $1,134 | $32 |
| Oxybutynin Chloride | 18 | $944 | $52 |
| Sulfamethoxazole-Trimethoprim | 156 | $922 | $6 |
| Hydrocodone-Acetaminophen | 124 | $896 | $7 |
| Doxazosin Mesylate | 35 | $630 | $18 |
| Allopurinol | 49 | $443 | $9 |
| Triamcinolone Acetonide | 53 | $379 | $7 |
| Ibuprofen | 78 | $319 | $4 |
| Levofloxacin | 19 | $202 | $11 |
| Sodium Chloride | 16 | $172 | $11 |
| Cephalexin | 24 | $170 | $7 |
| Terazosin | 28 | $158 | $6 |
| Acetaminophen-Codeine | 33 | $138 | $4 |
| Lorazepam | 50 | $133 | $3 |
| Ampicillin Trihydrate | 11 | $65 | $6 |
| Ketorolac Tromethamine | 17 | $48 | $3 |
2013: 40 drugs
| Vesicare | 417 | $88,501 | $212 |
| Avodart | 155 | $24,331 | $157 |
| Detrol La | 94 | $20,971 | $223 |
| Myrbetriq | 74 | $17,114 | $231 |
| Oxybutynin Chloride Er | 272 | $16,306 | $60 |
| Toviaz | 82 | $13,897 | $169 |
| Trospium Chloride Er | 53 | $9,886 | $187 |
| Premarin | 51 | $9,320 | $183 |
| Tamsulosin | 484 | $9,143 | $19 |
| Nystatin-Triamcinolone | 81 | $8,127 | $100 |
| Nitrofurantoin | 172 | $6,215 | $36 |
| Rapaflo | 35 | $5,265 | $150 |
| Trospium Chloride | 45 | $4,982 | $111 |
| Desmopressin Acetate | 55 | $4,756 | $86 |
| Testosterone Cypionate | 67 | $4,571 | $68 |
| Jalyn | 25 | $3,841 | $154 |
| Enablex | 22 | $3,818 | $174 |
| Gelnique | 13 | $3,126 | $240 |
| Bicalutamide | 50 | $2,728 | $55 |
| Finasteride | 111 | $1,803 | $16 |
| Bethanechol Chloride | 22 | $1,773 | $81 |
| Imipramine | 84 | $1,741 | $21 |
| Nitrofurantoin Mono-Macro | 51 | $1,718 | $34 |
| Ciprofloxacin | 216 | $1,394 | $6 |
| Sulfamethoxazole-Trimethoprim | 132 | $764 | $6 |
| Hydrocodone-Acetaminophen | 143 | $646 | $5 |
| Oxybutynin Chloride | 26 | $491 | $19 |
| Potassium Chloride | 15 | $405 | $27 |
| Allopurinol | 58 | $399 | $7 |
| Nystatin | 16 | $355 | $22 |
| Cephalexin | 36 | $282 | $8 |
| Ibuprofen | 64 | $193 | $3 |
| Doxazosin Mesylate | 11 | $176 | $16 |
| Sodium Chloride | 14 | $161 | $12 |
| Terazosin | 23 | $135 | $6 |
| Triamcinolone Acetonide | 15 | $121 | $8 |
| Levofloxacin | 21 | $107 | $5 |
| Lorazepam | 37 | $105 | $3 |
| Ampicillin Trihydrate | 12 | $77 | $6 |
| Ketorolac Tromethamine | 15 | $58 | $4 |
Money from drug and device companies
$792 in 2025
| 2025 | 9 | 31 | None | $792 |
| 2024 | 24 | 79 | None | $1,877 |
| 2023 | 14 | 53 | None | $1,209 |
| 2022 | 14 | 51 | None | $860 |
| 2021 | 15 | 58 | None | $1,080 |
| 2020 | 8 | 15 | None | $284 |
| 2019 | 6 | 18 | None | $477 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Janssen Biotech | Erleada | $282 | 6 payments
|
| Sumitomo Pharma America | Gemtesa | $167 | 10 payments
|
| Abbvie | Botox | $91 | 4 payments
|
| Antares Pharma | Xyosted | $56 | 2 payments
|
| Ferring Pharmaceuticals | Adstiladrin | $54 | 3 payments
|
| Accord Healthcare | Camcevi | $46 | 2 payments
|
See all 31 published payments
| Sumitomo Pharma America | Meals · 2025-12-22 | Gemtesa | $6 |
| Abbvie | Meals · 2025-12-11 | Botox | $16 |
| AstraZeneca Pharmaceuticals LP | Education · 2025-11-13 | Imfinzi | $35 |
| Sumitomo Pharma America | Meals · 2025-11-12 | Gemtesa | $14 |
| Janssen Biotech | Meals · 2025-11-07 | Erleada | $38 |
| Janssen Biotech | Meals · 2025-10-08 | Erleada | $32 |
| Sumitomo Pharma America | Meals · 2025-09-17 | Gemtesa | $24 |
| Ferring Pharmaceuticals | Meals · 2025-09-10 | Adstiladrin | $16 |
| Astellas Pharma US | Meals · 2025-08-18 | Xtandi | $26 |
| Abbvie | Meals · 2025-08-06 | Botox | $14 |
| Janssen Biotech | Meals · 2025-07-30 | Erleada | $41 |
| Sumitomo Pharma America | Meals · 2025-07-09 | Gemtesa | $24 |
| Ferring Pharmaceuticals | Meals · 2025-07-07 | Adstiladrin | $17 |
| Coloplast | Meals · 2025-06-26 | Coloplast Tfl Drive | $14 |
| Sumitomo Pharma America | Meals · 2025-06-11 | Gemtesa | $14 |
| Accord Healthcare | Meals · 2025-06-11 | Camcevi | $24 |
| Janssen Biotech | Meals · 2025-06-04 | Erleada | $37 |
| Accord Healthcare | Meals · 2025-05-28 | Camcevi | $22 |
| Abbvie | Meals · 2025-05-27 | Botox | $31 |
| Ferring Pharmaceuticals | Meals · 2025-05-19 | Adstiladrin | $21 |
| Janssen Biotech | Education · 2025-05-07 | Erleada | $99 |
| Sumitomo Pharma America | Meals · 2025-04-30 | Gemtesa | $24 |
| Coloplast | Meals · 2025-04-29 | Altis | $21 |
| Janssen Biotech | Meals · 2025-04-14 | Erleada | $35 |
| Sumitomo Pharma America | Meals · 2025-04-07 | Gemtesa | $11 |
| Abbvie | Meals · 2025-04-03 | Botox | $30 |
| Antares Pharma | Meals · 2025-02-24 | Xyosted | $34 |
| Sumitomo Pharma America | Meals · 2025-02-19 | Gemtesa | $21 |
| Sumitomo Pharma America | Meals · 2025-02-13 | Gemtesa | $4 |
| Antares Pharma | Meals · 2025-01-28 | Xyosted | $23 |
| Sumitomo Pharma America | Meals · 2025-01-22 | Gemtesa | $24 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $1,877
| Accord Healthcare | Camcevi | $237 | 13 payments
|
| Astellas Pharma US | Xtandi | $225 | 4 payments
|
| Sumitomo Pharma America | Gemtesa | $196 | 10 payments
|
| Janssen Biotech | Erleada | $192 | 4 payments
|
| Antares Pharma | Xyosted | $176 | 10 payments
|
| Urogen Pharma | Jelmyto | $147 | 6 payments
|
| Abbvie | Lupron Depot | $103 | 4 payments
|
| Myriad Genetic Laboratories | Prolaris | $101 | 4 payments
|
| Dendreon Pharmaceuticals | Provenge | $91 | 3 payments
|
| Telix Pharmaceuticals | Illuccix | $81 | 5 payments
|
| Pfizer | Xtandi | $52 | 2 payments
|
| Merck Sharp & Dohme | Keytruda | $45 | 2 payments
|
| Novartis Pharmaceuticals | Pluvicto | $34 | 1 payment
|
| Olympus America | Itind System | $24 | 1 payment
|
| Boston Scientific | Ams 700 | $22 | 1 payment
|
| KARL STORZ Endoscopy-America | N.A. | $20 | 1 payment
|
| Coloplast | Isiris A | $19 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Lynparza | $18 | 1 payment
|
| Immunitybio | Anktiva | $17 | 1 payment
|
| Axonics | Axonics | $17 | 1 payment
|
| Tolmar | Jatenzo | $16 | 1 payment
|
| ConvaTec | Gentlecath Glide | $15 | 1 payment
|
| Laborie Medical Technologies | Eclipse | $14 | 1 payment
|
| Ferring Pharmaceuticals | Adstiladrin | $14 | 1 payment
|
2023: $1,209
| Myriad Genetic Laboratories | Prolaris | $230 | 8 payments
|
| Dornier MedTech America | Dornier Medtech | $184 | 1 payment
|
| Astellas Pharma US | Xtandi | $173 | 15 payments
|
| AbbVie | Lupron Depot | $99 | 6 payments
|
| Sumitomo Pharma America | Gemtesa | $91 | 4 payments
|
| Telix Pharmaceuticals | Illuccix | $73 | 4 payments
|
| Teleflex | Urolift | $70 | 3 payments
|
| Janssen Biotech | Erleada | $57 | 3 payments
|
| Boston Scientific | Rezum Generator | $57 | 2 payments
|
| UroGen Pharma | Jelmyto | $57 | 2 payments
|
| Tolmar | Eligard | $49 | 2 payments
|
| Pfizer | Xtandi | $28 | 1 payment
|
| Supernus Pharmaceuticals | Xyosted | $26 | 1 payment
|
| Dentsply Ih Ab | Lofric | $15 | 1 payment
|
2022: $860
| Urovant Sciences | Gemtesa | $310 | 17 payments
|
| Astellas Pharma US | Myrbetriq | $210 | 17 payments
|
| Abbvie | Lupron Depot | $58 | 3 payments
|
| Myriad Genetic Laboratories | Prolaris | $54 | 2 payments
|
| Myovant Sciences | Orgovyx | $45 | 2 payments
|
| Bayer HealthCare Pharmaceuticals | Nubeqa | $28 | 1 payment
|
| Axonics | Axonics | $25 | 2 payments
|
| TOLMAR Pharmaceuticals | Eligard | $22 | 1 payment
|
| UroGen Pharma | Jelmyto | $21 | 1 payment
|
| Antares Pharma | Nocdurna | $21 | 1 payment
|
| 180 Medical | Gentlecath | $19 | 1 payment
|
| Janssen Biotech | Erleada | $18 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Lynparza | $16 | 1 payment
|
| Coloplast | Titan | $15 | 1 payment
|
2021: $1,080
| Dendreon Pharmaceuticals | Provenge | $253 | 9 payments
|
| Astellas Pharma US | Myrbetriq | $167 | 13 payments
|
| Coloplast | Titan | $144 | 7 payments
|
| Myovant Sciences | Orgovyx | $112 | 9 payments
|
| Boston Scientific | General - Bph | $90 | 2 payments
|
| TOLMAR Pharmaceuticals | Eligard | $71 | 4 payments
|
| Urogen Pharma | Jelmyto | $55 | 3 payments
|
| Urovant Sciences | Gemtesa | $40 | 2 payments
|
| Antares Pharma | Xyosted | $31 | 2 payments
|
| Janssen Biotech | None | $28 | 2 payments
|
| Allergan | Botox | $27 | 1 payment
|
| Bayer HealthCare Pharmaceuticals | Nubeqa | $18 | 1 payment
|
| AbbVie | Lupron Depot | $18 | 1 payment
|
| Teleflex | Urolift System | $14 | 1 payment
|
| Olympus America | Itind System | $12 | 1 payment
|
2020: $284
| Dendreon Pharmaceuticals | Provenge | $118 | 6 payments
|
| Coloplast | Continence Care | $50 | 2 payments
|
| Ferring Pharmaceuticals | Firmagon | $31 | 2 payments
|
| Boston Scientific | General - Bph | $25 | 1 payment
|
| AbbVie | Lupron Depot | $22 | 1 payment
|
| Bayer HealthCare Pharmaceuticals | Nubeqa | $13 | 1 payment
|
| NeoTract | Urolift | $13 | 1 payment
|
| Axonics Modulation Technologies | Axonics R-Snm System | $12 | 1 payment
|
2019: $477
| Coloplast | Titan | $159 | 1 payment
|
| Dendreon Pharmaceuticals | Provenge | $135 | 6 payments
|
| Boston Scientific | General Bph | $87 | 4 payments
|
| Ferring Pharmaceuticals | Firmagon | $66 | 5 payments
|
| AbbVie | Lupron Depot | $19 | 1 payment
|
| Astellas Pharma US | Xtandi | $11 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 69.9 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1861685786
- Licence
- CA G33716California G33716: Current · expires 2027-01-31
- Trained
- Georgetown University School of Medicine, 1972 · 54 years ago
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Urology (208800000X)
- Mailing address
- 220 Standiford Ave Ste F, Modesto, CA, 95350
- NPI first listed
- 2007-08-23
- NPI last updated
- 2021-07-23
- NPI record certified
- 2021-07-23
This is when the NPI record was last certified, not a medical board exam.